A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will respond to new therapies. The research, published in Clinical Cancer Research, found that measuring the interaction between two proteins, RAS and RAF, could provide valuable insights into the effectiveness of treatments for patients with KRASG12C-mutant non-small cell lung cancer, a type of lung cancer known for being particularly difficult to treat.
How scientists redesigned an effective cancer therapy to make it safer
University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage. If approved, the new drug may be tolerated by a broader range of leukemia patients and even be used to treat other cancers.
Early intervention with iron delivered intravenously during pregnancy found safe and effective treatment for anemia
Anemia during pregnancy is a common occurrence and often due to iron deficiency. It is a global public health problem, affecting an estimated 37% of pregnant individuals, according to the World Health Organization. Iron deficiency anemia is associated with increased rates of pregnancy-related problems, such as going into labor prematurely, hemorrhaging and, in some cases, even death. For the infant, maternal iron deficiency also can have long-term implications on their overall health and development.
Watch what you eat: NFL game advertisements promote foods high in fat and sodium
Research from Saint Louis University (SLU) and the University of Nevada, Reno School of Medicine finds that some of the most-watched ads promote the worst food options for adults with chronic health conditions.
Researchers link India’s food program to better health and stronger incomes
Despite humanity’s scientific achievements and globalized economy, malnutrition remains a global issue. The United Nations estimated that 2.33 billion people experienced moderate or severe food insecurity in 2023.
FDA approves Datroway for HR-positive, HER2-negative breast cancer
The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with unresectable or metastatic, hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.
Temperature exposure linked to adolescent psychiatric symptoms
Exposure to cold in the Netherlands and to heat in Spain appears to be associated with more psychiatric symptoms among adolescents, according to a study published online Jan. 28 in JAMA Network Open.
Intermittent fasting aids some outcomes for postmenopausal women with rheumatoid arthritis
Intermittent fasting may benefit antioxidant and inflammatory markers in postmenopausal women with rheumatoid arthritis, according to a study published online Jan. 18 in Scientific Reports.
Bird flu studies delayed as White House halts CDC reports
As a bird flu outbreak escalates across the U.S., the Trump administration has paused the release of key public health studies, stalling research that could provide insight into how the virus spreads to animals and people.
FDA approves first new non-opioid pain pill in decades
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.